regenerative medicine bioprinting

Bioprinting has long been praised as a groundbreaking tool for advancing regenerative medicine, drug testing, and tissue engineering. But despite its immense potential, the high cost of bioprinters has kept…

Pioneering solutions for metabolic and endocrine diseases, Vancouver-based Aspect Biosystems raised $115 million in Series B funding to advance its bioprinted tissue technology. Led by investment firm Dimension, the round…

The future of bioprinting is full of potential, with new trends that could impact the industry. These upcoming developments could drive the next wave of innovation, expanding what’s possible in…

A research team from the Catholic University of Korea has successfully implanted the world’s first bioprinted artificial trachea into a patient, customized using adult stem cells from another person. Led…

We’re starting off with a process certification in today’s 3D Printing News Briefs, and then moving on to research about solute trapping, laser powder bed fusion, and then moving on…

3D Systems, the additive manufacturing (AM) pioneer based in South Carolina, has launched the Regenerative Tissue Program, a bioprinting project for patient-specific, living human tissues. By combining the company’s bioprinting…

French regenerative medicine firm Healshape is preparing to raise $6.8 million through an ongoing seed-funding activity to scale and industrialize the production of 3D bioprinted breast implants for mammary reconstruction…

As Swedish bioprinter manufacturer Fluicell prepares to enter the regenerative medicine market through its BioRej Advance program, it focuses on developing therapeutic products based on bioprinted transplantable microtissues targeting important…

Leading bioprinter manufacturer Rokit Healthcare is gearing up for its Initial Public Offering (IPO) as early as July 2021. In March 2021, the South Korean company announced it is preparing…

After markets closed on March 1, 2021, 3D Systems (NYSE: DDD) announced its financial results for the fourth quarter and full-year 2020. The Rock Hill, South Carolina-based 3D printing solutions…

Automation, healthcare, metal additive manufacturing (AM), and bioprinting were the four big topics discussed at the 2021 Additive Manufacturing Strategies (AMS) summit. The two-day virtual event gathered experts for panel…

Startup Accelerator is an article series with a focus on new and exciting companies in the 3D printing space, in which 3DPrint.com speaks to startup leadership about their unique technologies…

The European consortium OrganTrans is preparing to develop a tissue engineering platform capable of generating liver tissue. The proposed automated and standardized disruptive alternative solution to organ donation for patients…

Managing bone defects and injuries using traditional treatments can be slow and expensive. When bones break, bone cells can usually repair them, unless the break is too large. In that…

In his 19-year career as a strategic business manager, Simon MacKenzie has come to be identified by his efforts to generate collaborative alliances in biotechnology. His most recent crusade has…

A team of researchers at Texas A&M University (TAMU) have developed a 3D printable hydrogel bioink containing mineral nanoparticles that can deliver protein therapeutics to control cell behavior. TAMU researchers led…

In the paper “Three‐Dimensional Bioprinting in Regenerative Medicine: Reality, Hype, and Future,” authors Anthony Atala and Gabor Forgacs explore some necessary topics within 3D printing and bioprinting. The technology has…

3D printing continues to make a huge impact on the medical field – the evidence more than speaks for itself. But this important work is not done yet. A team…

3D printing is widely used today for a variety of new applications—from recyclable cars to robots that work with 3D printers to make auto repairs. We may see homes and office…